Capital BioVentures Launches first cohort for the ASCENT program: Fit for funding, empowering breakthrough biotech
Capital BioVentures (CBV), a leading biotech accelerator, dedicated to supporting the growth of early-stage life sciences companies, is proud to announce the launch of its newest offering, the ASCENT Program.…